Clinical trial
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and…
NCT00124293 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00124293 |
|---|---|
| Title | Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury |
| Official title | A Multi Centre Observational Study to Evaluate the Incidence and Magnitude of Haemorrhagic Progression of Cerebral Contusions and the Identification of Important Safety Issues Following Traumatic Brain Injury |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Acquired Bleeding Disorder, Trauma |
| Intervention type | Drug |
| Interventions | activated recombinant human factor VII |
| Enrollment | 63 |
| Start date | Oct 6, 2004 |
| Primary completion | Nov 23, 2005 |
| Completion | Nov 23, 2005 |
| First posted | Jul 27, 2005 |
| Last update posted | Feb 27, 2017 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: